Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Cencora, Inc.

Cash and Cash Equivalents

Cash and Cash Equivalents %Chg

Cash and Cash Equivalents Common Size

Accounts Receivable, Net

Accounts Receivable, Net %Chg

Accounts Receivable, Net Common Size

Inventories

Inventories %Chg

Inventories Common Size

Right-of-Use Assets

Right-of-Use Assets %Chg

Right-of-Use Assets Common Size

Income Tax Receivable

Income Tax Receivable %Chg

Income Tax Receivable Common Size

Prepaid Expenses and Other

Prepaid Expenses and Other %Chg

Prepaid Expenses and Other Common Size

Assets Held for Sale

Assets Held for Sale %Chg

Assets Held for Sale Common Size

Total Current Assets

Total Current Assets %Chg

Total Current Assets Common Size

Land

Land %Chg

Land Common Size

Buildings and Improvements

Buildings and Improvements %Chg

Buildings and Improvements Common Size

Machinery, Equipment, and Other

Machinery, Equipment, and Other %Chg

Machinery, Equipment, and Other Common Size

Total Property and Equipment

Total Property and Equipment %Chg

Total Property and Equipment Common Size

Less Accumulated Depreciation

Less Accumulated Depreciation %Chg

Less Accumulated Depreciation Common Size

Property and Equipment, Net

Property and Equipment, Net %Chg

Property and Equipment, Net Common Size

Goodwill and Other Intangible Assets

Goodwill and Other Intangible Assets %Chg

Goodwill and Other Intangible Assets Common Size

Goodwill

Goodwill %Chg

Goodwill Common Size

Other Intangible Assets

Other Intangible Assets %Chg

Other Intangible Assets Common Size

Deferred Income Taxes

Deferred Income Taxes %Chg

Deferred Income Taxes Common Size

Other Assets

Other Assets %Chg

Other Assets Common Size

Total Assets

Total Assets %Chg

Total Assets Common Size

Accounts Payable

Accounts Payable %Chg

Accounts Payable Common Size

Accrued Expenses and Other

Accrued Expenses and Other %Chg

Accrued Expenses and Other Common Size

Short-Term Debt

Short-Term Debt %Chg

Short-Term Debt Common Size

Liabilities Held for Sale

Liabilities Held for Sale %Chg

Liabilities Held for Sale Common Size

Total Current Liabilities

Total Current Liabilities %Chg

Total Current Liabilities Common Size

Long-Term Debt

Long-Term Debt %Chg

Long-Term Debt Common Size

Long-Term Financing Obligation

Long-Term Financing Obligation %Chg

Long-Term Financing Obligation Common Size

Accrued Income Taxes

Accrued Income Taxes %Chg

Accrued Income Taxes Common Size

Accrued Litigation Liability

Accrued Litigation Liability %Chg

Accrued Litigation Liability Common Size

Other Liabilities

Other Liabilities %Chg

Other Liabilities Common Size

Common Stock

Common Stock %Chg

Common Stock Common Size

Additional Paid-in Capital

Total Cash and Cash Equivalents

Total Cash and Cash Equivalents %Chg

Total Cash and Cash Equivalents Common Size

Accounts Receivable

Accounts Receivable %Chg

Accounts Receivable Common Size

Total Trade Receivables

Total Trade Receivables %Chg

Total Trade Receivables Common Size

Other Current Assets

Other Current Assets %Chg

Other Current Assets Common Size

Net Property, Plant & Equipment

Net Property, Plant & Equipment %Chg

Net Property, Plant & Equipment Common Size

Net Intangible Assets

Net Intangible Assets %Chg

Net Intangible Assets Common Size

Other Long-Term Assets

Other Long-Term Assets %Chg

Other Long-Term Assets Common Size

Accrued Expenses

Accrued Expenses %Chg

Accrued Expenses Common Size

Other Current Liabilities

Other Current Liabilities %Chg

Other Current Liabilities Common Size

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Assets	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Cash and Cash Equivalents	4,356.1	2,231.9	1,978.1	3,224.3	3,132.6	3,306.2
Cash and Cash Equivalents
Total Cash and Cash Equivalents	4,356.1	2,231.9	1,978.1	3,224.3	3,132.6	3,306.2
Accounts Receivable	25,225.3	24,561.7	23,715	24,545.7	23,871.8	24,051.5
Accounts Receivable, Net
Total Trade Receivables	25,225.3	24,561.7	23,715	24,545.7	23,871.8	24,051.5
Inventories	20,492.5	20,137.8	18,965.5	20,508	18,998.8	18,301.5
Inventories
Other Current Assets	2,165.2	1,882.7	1,876.4	1,708.6	1,714.5	1,648
Right-of-Use Assets
Income Tax Receivable
Prepaid Expenses and Other
Assets Held for Sale
Total Current Assets	52,239.1	48,814.2	46,535	49,986.6	47,717.8	47,307.3
Total Current Assets
Net Property, Plant & Equipment	2,539.1	2,431.4	2,302.8	2,099.8	2,181.4	2,080.9
Property and Equipment, Net
Net Intangible Assets	3,774.2	3,929.1	3,862.8	3,682.2	4,001	4,010.9
Other Intangible Assets
Goodwill	13,676.5	14,326.1	14,091.4	9,177.2	9,318	9,613.7
Goodwill
Other Long-Term Assets	4,361.3	4,456.3	4,401.8	4,108.4	3,883.4	3,759.7
Deferred Income Taxes
Other Assets
Total Assets	76,590.1	73,956.9	71,193.9	69,054.3	67,101.7	66,772.4
Total Assets

Liabilities	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Accounts Payable	54,719.8	51,043.9	50,110.6	49,910.9	50,942.2	49,883
Accounts Payable
Accrued Expenses	2,963	2,717.4	2,447.5	2,385	2,758.6	2,525.7
Accrued Expenses and Other
Short-Term Debt	137.8	196.8	770.3	2,213.2	576.3	565.1
Short-Term Debt
Other Current Liabilities	—	—	—	—	—	—
Deferred Income Taxes
Liabilities Held for Sale
Total Current Liabilities	57,820.5	53,958	53,328.4	54,509.1	54,277.1	52,973.9
Total Current Liabilities
Long-Term Debt	7,543	8,043.7	7,085.9	5,935.3	3,811.7	4,165.9
Long-Term Debt
Long-Term Financing Obligation
Other Long-Term Liabilities	8,979.5	9,745.3	9,599.8	8,248	8,223.6	8,572.1
Accrued Income Taxes
Deferred Income Taxes
Accrued Litigation Liability
Other Liabilities
Total Long-Term Liabilities	16,522.4	17,789	16,685.7	14,183.3	12,035.3	12,738.1
Total Liabilities	74,343	71,747	70,014.1	68,692.4	66,312.4	65,711.9

Equity	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Common Stock	3	3	3	3	3	3
Common Stock
Treasury Stock	-10,332.1	-10,332	-10,331.9	-10,277.9	-9,815.8	-9,302.5
Treasury Stock, at Cost
Additional Paid-in Capital	6,204.3	6,172	6,142.1	6,106.3	6,030.8	5,989.2
Additional Paid-in Capital
Accumulated Other Comprehensive Income	-1,199.5	-844.2	-1,201.8	-1,399.6	-1,000.6	-1,279.2
Accumulated Other Comprehensive Loss
Retained Earnings	6,534.2	6,981.4	6,401.5	5,794.9	5,417.1	5,514.7
Retained Earnings
Total Common Shareholders' Equity	1,508	1,980.2	1,012.8	226.6	645.9	925.2
Total AmerisourceBergen Corporation Stockholders' Equity
Total Cencora, Inc. Stockholders' Equity
Minority Interests and Other	239.1	229.7	167	135.3	140.8	135.3
Noncontrolling Interests
Total Shareholders' Equity	1,747.1	2,209.9	1,179.8	361.9	786.7	1,060.5
Total Stockholders' Equity
Total Liabilities and Shareholders' Equity	76,590.1	73,956.9	71,193.9	69,054.3	67,101.7	66,772.4
Total Liabilities and Stockholders' Equity